These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 26915580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM, Cikes M, Prasad N, Li G, Getchevski S, Claggett B, Rizkala A, Lukashevich I, O'Meara E, Ryan JJ, Shah SJ, Mullens W, Zile MR, Lam CSP, McMurray JJV, Solomon SD, PARAGON-HF Investigators.
    J Am Coll Cardiol; 2019 Dec 10; 74(23):2858-2873. PubMed ID: 31806129
    [Abstract] [Full Text] [Related]

  • 4. Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia.
    Pan JA, Lin H, Wang CQ, Zhang JF, Gu J.
    Heart Vessels; 2020 Oct 10; 35(10):1446-1453. PubMed ID: 32430700
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of Left Ventricular Relaxation and Left Atrial Function in Patients With Heart Failure and Preserved Ejection Fraction Versus Patients With Systemic Hypertension and Healthy Subjects.
    Okura H, Kataoka T, Yoshida K.
    Am J Cardiol; 2016 Oct 01; 118(7):1019-23. PubMed ID: 27515892
    [Abstract] [Full Text] [Related]

  • 9. Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction.
    Biering-Sørensen T, Shah SJ, Anand I, Sweitzer N, Claggett B, Liu L, Pitt B, Pfeffer MA, Solomon SD, Shah AM.
    Eur J Heart Fail; 2017 Aug 01; 19(8):1043-1052. PubMed ID: 28322009
    [Abstract] [Full Text] [Related]

  • 10. The impact of right ventricular dysfunction on the effectiveness of beta-blockers in heart failure with preserved ejection fraction.
    Harada D, Asanoi H, Noto T, Takagawa J.
    J Cardiol; 2020 Oct 01; 76(4):325-334. PubMed ID: 32475652
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of left ventricular diastolic function profile in patients with pulmonary hypertension due to heart failure with preserved ejection fraction.
    Raeisi-Giglou P, Lam L, Tamarappoo BK, Newman J, Dweik RA, Tonelli AR.
    Clin Cardiol; 2017 Jun 01; 40(6):356-363. PubMed ID: 28026030
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L, Cinca J, Vazquez-García R, Gonzalez-Juanatey JR, Rivera M, Segovia J, Pascual-Figal D, Bover R, Worner F, Delgado-Jiménez J, Fernández-Avilés F, Martínez-Sellés M.
    Intern Med J; 2019 Dec 01; 49(12):1505-1513. PubMed ID: 30887642
    [Abstract] [Full Text] [Related]

  • 17. Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH).
    Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, Edelmann F, Filippatos G, Gruson D, Ikonomidis I, Lhommel R, Mahmod M, Neubauer S, Persu A, Gerber BL, Piechnik S, Pieske B, Pieske-Kraigher E, Pinto F, Ponikowski P, Senni M, Trochu JN, Van Overstraeten N, Wachter R, Balligand JL.
    ESC Heart Fail; 2018 Oct 01; 5(5):830-841. PubMed ID: 29932311
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L, Liebelt JJ, Madan N, Shan J, Taub CC.
    Am J Cardiol; 2017 Jun 01; 119(11):1815-1820. PubMed ID: 28450040
    [Abstract] [Full Text] [Related]

  • 19. Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction.
    Li S, Li X.
    High Blood Press Cardiovasc Prev; 2019 Oct 01; 26(5):405-411. PubMed ID: 31625118
    [Abstract] [Full Text] [Related]

  • 20. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH, Benson L, Dahlström U, Edner M, Friberg L.
    JAMA; 2014 Nov 19; 312(19):2008-18. PubMed ID: 25399276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.